The meeting will feature a comprehensive education program offering technical sessions, shedding light on the latest advancements in areas like supply chain, operations, facilities, and regulatory affairs, but also emphasizing the role of data science including model-informed drug development (MIDD) and technology in shaping the future of product development, production systems, and quality assurance.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze